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Approximately 10% of humans with anophthalmia (absent eye) or severe microphthalmia (small eye) show
haploid insufficiency due to mutations in SOX2, a SOXB1-HMG box transcription factor. However, at present,
the molecular or cellular mechanisms responsible for these conditions are poorly understood. Here, we
directly assessed the requirement for SOX2 during eye development by generating a gene-dosage allelic series
of Sox2 mutations in the mouse. The Sox2 mutant mice display a range of eye phenotypes consistent with
human syndromes and the severity of these phenotypes directly relates to the levels of SOX2 expression found
in progenitor cells of the neural retina. Retinal progenitor cells with conditionally ablated Sox2 lose
competence to both proliferate and terminally differentiate. In contrast, in Sox2 hypomorphic/null mice, a
reduction of SOX2 expression to <40% of normal causes variable microphthalmia as a result of aberrant
neural progenitor differentiation. Furthermore, we provide genetic and molecular evidence that SOX2 activity,
in a concentration-dependent manner, plays a key role in the regulation of the NOTCH1 signaling pathway in
retinal progenitor cells. Collectively, these results show that precise regulation of SOX2 dosage is critical for
temporal and spatial regulation of retinal progenitor cell differentiation and provide a cellular and molecular
model for understanding how hypomorphic levels of SOX2 cause retinal defects in humans.
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Seven main classes of retinal cell types (rod, cone, bipo-
lar, horizontal, amacrine, ganglion, and Müller glial
cells) are produced from a pool of multipotent retinal
progenitor cells (RPC). The overall size of the retina, and
the proportion of each of these cell types contained
therein is essential for proper visual processing. To en-
sure that the adult retina forms appropriately during de-
velopment, RPCs transition through states of develop-
mental competence by coordinating cell cycle exit and
cell fate specification to generate an ordered array of
uniquely fated cell populations (Dyer and Cepko 2001;
Fujita 2003; Pearson and Doe 2004; Zhang et al. 2004;
Kageyama et al. 2005). When these processes are dis-
rupted, as observed in some cases of human micro-
phthalmia and anophthalmia (Zigman and Paxhia 1988;
Loosli et al. 1998; Fantes et al. 2003; Driver et al. 2005;
Fitzpatrick and van Heyningen 2005; Labadie et al. 2005;
O’Brien et al. 2005; Ragge et al. 2005a,b; Xu et al. 2005),
vision is severely compromised. Identifying the molecu-
lar mechanisms that allow some progenitors to continu-
ally divide yet promote neighboring cells to stop dividing
and differentiate at appropriate times during develop-
ment is pivotal to the understanding of both normal and
defective retinal development.
It has recently been shown that mutations in SOX2 a
SOXB1-HMG box transcription factor whose expression
universally marks neural stem and progenitor cells
throughout the CNS including the neural retina (Col-
lignon et al. 1996; Zappone et al. 2000; D’Amour and
Gage 2003; Ellis et al. 2004; Ferri et al. 2004), are asso-
ciated with retinal and ocular malformations in humans.
The resulting haploid insufficiency at the SOX2 locus
occurs in ∼10% of human individuals with anophthal-
mia or severe microphthalmia (Fantes et al. 2003; Fitz-
patrick and van Heyningen 2005; Hagstrom et al. 2005;
Ragge et al. 2005a,b; Zenteno et al. 2005). Most muta-
tions identified to date are point mutations leading to
truncations of SOX2, while a smaller class of mutations
includes microdeletions and missense point mutations.
Interestingly, all mutations produce hypomorphic con-
ditions, where residual SOX2 expression and function
are still preserved, albeit at lower levels, leading to the
highly variable severity of the clinical phenotype. In this
regard, the SOX2 mutations in humans and the clinical
consequence of reduced functional levels of SOX2 sug-
gest a dosage-dependent role for SOX2 during retinal pro-
genitor differentiation.
To date, the importance of SOX2 in the nervous sys-
tem has been highlighted by misexpression and domi-
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nant interfering studies in mouse cell lines, Xenopus,
and chick embryos, which suggests that SOX2 maintains
neural progenitor identity (Mizuseki et al. 1998; Kishi et
al. 2000; Bylund et al. 2003; Graham et al. 2003; Pevny
and Placzek 2005; Van Raay et al. 2005). However, the
lethality of Sox2-null mutant mice at the preimplanta-
tion stage (Avilion et al. 2003) combined with the over-
lap in expression and potential functional redundancy of
the three highly related SOXB1 factors (SOX1, SOX2, and
SOX3) in CNS progenitors (Collignon et al. 1996; Pevny
et al. 1998; Weiss et al. 2003; Rizzoti et al. 2004; Tanaka
et al. 2004) have precluded genetic evaluation of the spe-
cific role of SOX2 in neural progenitor cells.
Unlike the extensive overlap of their expression in the
rest of the CNS, SOXB1 factors display unique patterns
of expression in the developing eye (Kamachi et al. 1998,
2001; Nishiguchi et al. 1998; Uchikawa et al. 1999, 2003;
Le et al. 2002). SOX1, SOX2, and SOX3 are initially ex-
pressed in the anterior neural plate and invaginating op-
tic vesicle. However, during the formation of the optic
cup, SOX1 and SOX3 are down-regulated, while SOX2 is
maintained and restricted to neural retinal cells (Kama-
chi et al. 1998, 2001; Le et al. 2002). Thus, the selective
expression of SOX2, and not SOX1 or SOX3, in the neu-
ral retina, coupled with cellular and molecular parallels
between ventricular zone and retinal CNS progenitor dif-
ferentiation, provides an ideal in vivo model system to
evaluate the unique contribution of SOX2 in neural pro-
genitor populations (Collignon et al. 1996; Kamachi et al.
1998; Nishiguchi et al. 1998; Le et al. 2002; Uchikawa et
al. 2003; Blackshaw et al. 2004).
To dissect out the retinal-specific roles of SOX2 and to
determine the effect of SOX2 dosage on these roles, here
we report the examination of systematic dosage reduc-
tion of SOX2 on retinal progenitor differentiation using
conditional/null, compound hypomorphic/null, and het-
erozygous/null and wild-type mice. First, we show that
conditional ablation of SOX2 in the mouse retina causes
the complete loss of neural progenitor competence to
divide and differentiate. Second, and in contrast with
complete ablation of SOX2, hypomorphic levels of SOX2
expression trigger aberrant retinal progenitor differentia-
tion, resulting in variable microphthalmic phenotypes.
In addition, using two independent approaches we dem-
onstrate that SOX2, acting as a transcription factor, me-
diates its effects by directly regulating the expression
levels of NOTCH1. These studies provide direct cellular
and molecular evidence that alterations in the levels of
SOX2 regulate the choice between maintenance of pro-
genitor cell identity and differentiation. Moreover, these
data reveal a molecular basis for retinal defects in hu-
mans, which present as anophthalmia and microphthal-
mia syndromes, as a consequence of hypomorphic levels
of SOX2.
Results
SOX2 defines retinal progenitor cells
Previous studies have shown that SOX2 expression
marks proliferating neural progenitors and is down-regu-
lated in the CNS ventricular zone concomitant with
their differentiation (Ellis et al. 2004; Ferri et al. 2004;
Rizzoti et al. 2004; Tanaka et al. 2004). We therefore
addressed whether SOX2 expression is regulated in a
similar dynamic manner in RPCs. RPC differentiation
results in the formation of discrete layers; progenitor
cells are retained in the outer retinoblast layer (RBL) (ar-
row in Fig. 1B), while cells that exit the cell cycle are
located in the inner ganglion cell layer (GCL) (arrow in
Fig. 1D). Upon exiting the cell cycle, retinal progenitors
differentiate into six defined neuronal cell types in a pre-
cise temporal and spatial manner (Cepko et al. 1996; Reh
and Fischer 2001). Retinal ganglion cells (RGCs) are gen-
erated first, followed by overlapping phases of develop-
ment for horizontal cells, cones, amacrine cells, rods,
and bipolar cells. Using a Sox2EGFP-reporter mouse line
in which the SOX2 coding region is replaced by en-
hanced green fluorescent protein (EGFP) such that EGFP
fluorescence recapitulates SOX2 expression (Ellis et al.
2004) we show that, as in the CNS ventricular zone,
SOX2 and EGFP (Fig. 1A,E) expression in the embryonic
retina coincides with markers of cell proliferation such
as Proliferating Cell Nuclear Antigen (PCNA) (Fig. 1B,F).
However, in contrast to CNS ventricular zone progeni-
tors that also express SOX1 and SOX3, retinal neural
progenitors exclusively express SOX2 (Fig. 1 C,G). Coin-
cident with retinal cell differentiation, SOX2 (and EGFP)
expression is down-regulated such that its expression is
mutually exclusive of the general neuronal marker neu-
ron-specific class III TUBULIN (TUBULIN III) in the
GCL (Fig. 1D,H). Subsequently, SOX2 (and EGFP)
(Supplementary Fig. 6) is not detected in cells expressing
specific markers associated with each of the mature reti-
nal cell types including NEUROFILAMENT, a marker of
RGCs and horizontal cells (Fig. 1I,L), RHODOPSIN, a
marker of rod cells (Fig. 1J,M), and Protein Kinase C 
(PKC), a marker of bipolar cells (Fig. 1K,N). Consistent
with the expression pattern of Sox2 in the chick (Le et al.
2002), SOX2 is maintained in a small subset of cells iden-
tified as displaced amacrines by the coexpression of
ISLET1 (Fig. 1O,R) and CALRETININ (Fig. 1P,S). In con-
trast to its down-regulation in post-mitotic neuronal
cells, SOX2 is maintained in Müller glia, a nonneuronal
cell type of the mature retina, marked by Cellular Reti-
nal-Binding Protein (CRALBP) (Fig. 1Q,T) (Eisenfeld et
al. 1985) and Glial Fibrillary Acidic Protein (GFAP) (data
not shown) expression.
These analyses demonstrate that SOX2 expression in
both the neural retina and ventricular zone of the CNS is
inversely correlated with the progression of neuronal dif-
ferentiation, suggesting that there is a shared mecha-
nism regulated by SOX2.
A dosage-dependent role for SOX2 during retinal
progenitor differentiation
To analyze the effects of decreasing levels of SOX2 in
neural progenitor cells, we generated an allelic series
of Sox2 mutations in the mouse including a null
(Sox2EGFP), a conditional null (Sox2COND), and two hy-
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pomorphic (Sox2LP and Sox2IR) alleles. Sox2EGFP is a null
allele in which the Sox2 ORF has been substituted with
an EGFP expression cassette (Ellis et al. 2004). The
Sox2COND allele contains the Sox2 ORF flanked by loxP
sites such that CRE-mediated recombination results in
removal of the entire SOX2 coding sequence and gener-
ates a null allele (Sox2COND) (Fig. 2A,B), and Sox2LP and
Sox2IR were constructed by the insertion of PGK–neo-
loxP and IRESdsRED-loxP-flanked-PGKneo expression
cassettes, respectively, 3 of the Sox2 ORF (Fig. 2A,C,D).
Figure 1. SOX2 defines progenitor cell
population in the retina. SOX2 expression
was evaluated using Sox2+/EGFP (green)
mice (Ellis et al. 2004) and specific anti-
bodies (red). (A,E,B,F) At E15.5, Sox2-EGFP
fluorescence, SOX2, and PCNA are coex-
pressed in the RBL. (C,G) SOX1 expression
is restricted to lens cells. Sox2EGFP is
down-regulated in differentiating neurons,
as marked by TUBULINIII (D,H) NEU-
ROFILAMENT (I,L; inset in L; arrow in I);
RHODOPSIN (J,M; inset in M; arrow in J);
and PKC (K,N; inset in N). Sox2-EGFP ex-
pression was maintained in a subpopula-
tion of amacrine cells identified by ISLET1
(O,R; inset in R) and CALRETININ (P,S;
inset in S), and Müller glia stained for
CRALBP (Q,T; inset in T). (ONL) outer
nuclear layer; (OPL); outer plexiform layer
(INL); inner nuclear layer (IPL); inner
plexiform layer (GCL) ganglion cell layer.
Bars: A–H, 200 µm; I–T, 50 µm; I–T (in-
sets), 20 µm.
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Sox2LP and Sox2IR alleles effectively act as hypomorphic
alleles, displaying <40% activity in a Sox2-null genetic
background; Sox2 mRNA (data not shown) and protein
levels in cells isolated from embryonic day 14 (E14) CNS
cortex (Fig. 3A,B) and eyes (Fig. 3C,D) are decreased to
15%–30% and 20%–40% of wild type in Sox2EGFP/LP and
Sox2EGFP/IR mice, respectively.
Animals heterozygous for Sox2+/EGFP, Sox2+/COND,
Sox2+/IR, and Sox2+/LP and homozygous for Sox2COND/COND,
Sox2IR/IR, and Sox2LP/LP are viable, born in appropriate
Mendelian ratios, and are phenotypically and morpho-
logically indistinguishable from wild-type mice (Fig. 2E;
Supplementary Fig. 1). However, Sox2 hypomorphic/null
compound heterozygotes (Sox2EGFP/IR and Sox2EGFP/LP)
display a range of eye phenotypes from mild bilateral
microphthalmia to severe anophthalmia. Histological
analyses of postnatal Sox2EGFP/IR mice show that the
majority of mutant retinas are ∼30%–40% thinner than
wild-type retinas. The thinning of the retina is associ-
ated with a reduction in cell number resulting in the
decreased widths of the inner nuclear and plexiform lay-
ers (Fig. 3E,F). Additionally, a majority of mutant eyes
display areas with disrupted cell layering, consisting of
rosette structures (Fig. 3G; Fig. 6D–F [below]). By E14.5,
eyes in embryos of both Sox2 hypomorphic/null com-
pound heterozygotes (Sox2EGFP/IR and Sox2EGFP/LP) are
smaller than eyes of Sox2 heterozygous (Sox2+/EGFP) or
wild-type littermates (Sox2+/+) (Fig. 3H,I; Supplementary
Fig. 1) and, consistent with a dose-dependent function
for SOX2, complete ablation of SOX2 specifically in reti-
nal progenitors (P0-CRE;Sox2EGFP/COND) correlates
with a further reduction in eye size (Fig. 3J; see below).
SOX2 is required for the proliferative and
differentiation capacity of retinal progenitors
To determine the requirement for SOX2 in retinal pro-
genitor cells, we used a Cre-loxP strategy to condition-
ally inactivate Sox2 specifically in the mouse neural
retina. In P0-CREiresGFP mice, the expression of CRE
and GFP is regulated by a retina-specific mouse Pax6
regulatory element such that CRE-recombinase activity
is detected exclusively in the neural retina from E10.5
(Marquardt et al. 2001). Consistent with the general re-
Figure 2. Generation of allelic series of mouse Sox2
locus. (A) Targeting vector introduced two loxP sites
flanking the Sox2 promoter and mRNA coding regions.
Homologous recombination of this vector at the Sox2
genomic locus in ES cells resulted in the generation of
two alleles. Complete insertion of the vector generated
the Sox2COND allele, while partial incorporation of the
3 part of this vector generated the Sox2LP allele, which
contains only the 3 insertion, but not the 5 loxP site.
CRE-driven recombination in Sox2+/COND;ACTB-Cre
mice (in ACTB mice CRE recombinase is expressed in
the female germline) resulted in deletion of the Sox2
promoter and mRNA coding region as well as the Neo
cassette, generating a null allele (Sox2COND). (B) The
DNA recombination events were confirmed by South-
ern blot analysis of mouse tail DNA. (C) In targeting
vector B, the 3 UTR of Sox2 was replaced by internal
ribosome entry site (IRES) and dsRED2 coding sequence
followed by a Neo cassette flanked with two loxP sites.
The incorporation of the insertion into Sox2 locus gen-
erated the Sox2IR allele. The restriction enzymes used
were AvrII (A), NheI (N), EcoRI (RI), SalI (S), SpeI (Sp),
EcoRV (V). (D) Segregation of the alleles in the mouse
lines was confirmed by Southern blotting with the P1
after EcoRI digest. (E) Quantification of pups and em-
bryos of each genotype recovered from indicated breed-
ings.
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striction of CRE expression to distal retinal progenitor
cells in P0-CRE;Sox2COND/COND embryos (Sox2+/COND
were crossed to Sox2+/EGFP;P0-CRE and Sox2+/COND;
P0-CRE), SOX2 is eliminated from these cells (Fig. 4A,F
and B,G, respectively).
A hallmark of SOX2-expressing neural progenitors is
the maintenance of proliferative and differentiation ca-
pacity. It was shown previously that inhibition of SOX2
signaling by overexpression of a dominant interfering
form of SOX2 in chick neural progenitors results in their
premature exit from the cell cycle (Bylund et al. 2003;
Graham et al. 2003). By E13.5, retinas of Sox2COND/COND;
P0-CRE embryos (Fig. 4H) are significantly smaller in
size compared with Sox2+/COND;P0-CRE retinas (Fig.
4C) as shown by PCNA staining. To further determine
whether the hypocellular phenotype observed in
Sox2COND/COND;P0-CRE retinas is due to decreased
proliferation, we assayed the expression of PCNA and
incorporation of Bromodeoxy-Uridine (BrdU) into S
phase nuclei. Although PNCA (Fig. 4 H) remained ex-
pressed throughout the Sox2COND/COND;P0-CRE
retinas E13.5, there is a marked reduction of BrdU incor-
poration in cells of the distal retina of Sox2+/COND;P0-
CRE embryos compared with cells of the central retina,
thus indicating exit from cell cycle (Fig. 4I). In contrast,
BrdU labeling in control embryos (Sox2+/COND;P0-
CRE) is evenly distributed throughout the distal-central
retina (Fig. 4D). Furthermore, the DNA content of the
distal retina (GFP positive) cells of wild-type (Sox2+/COND;
P0-CRE) and mutant Sox2COND/COND;P0-CRE)
mice was compared using flowcytometric cell cycle
analysis. These data show that ablation of SOX2, specifi-
cally in the cells expressing P0-CRE, decreases the
number of cycling cells (S/G2/M) from 31% to 8%
(Supplementary Fig. 2). In addition to a decrease in BrdU
incorporation and exit from cell cycle, Sox2 mutant dis-
tal RPCs, while maintaining expression of PCNA and
PAX6, do not express molecular markers that define un-
differentiated cycling RPCs such as Notch1 (Fig. 4E,J)
and Hes-5 (Fig. 4K,P). Together these results demon-
strate that SOX2 is required for appropriate neural reti-
nal progenitor proliferation and maintenance of molecu-
lar markers that define progenitor identity.
To determine whether SOX2-null retinal cells that
exit cell cycle differentiate into post-mitotic neurons,
we assayed the expression of neuronal markers Math5,
NeuroD, TUBULINIII (Fig. 4L–N,Q–S), and ISLET1
(data not shown). In distal regions of Sox2COND/COND;
P0-CRE retinas, Math5, NeuroD, and TUBULINIII
were absent (Fig. 4Q–S). Thus, complete genetic ablation
Figure 3. Analysis of Sox2IR and Sox2LP hypomorphic alleles. (A,C) Immunoblot of protein extracts from wild-type and Sox2 mutant
embryos; E14.5 brains and eyes, respectively, were developed with antibodies against SOX2. -ACTIN antibody was used as a loading
quantity control and an antibody against EGFP was used to control for the amount of putative SOX2 expressing cells in the sample.
Note that the expression level of EGFP from the Sox2 locus is preserved throughout. (B,D) Quantification of the immunoblot results.
SOX2 expression in Sox2+/+ was taken as baseline (100%), and EGFP expression in Sox2+/EGFP was designated as 50%. N = 2 for each
genotype. (E–G) Compared with the Sox2 heterozygous mouse (Sox2+/EGFP; E), the compound null hypomorphic adult (Sox2EGFP/IR; F)
shows a significant reduction in the thickness of the retina. By E14.5, the null hypomorph exhibits distinct rosette structures
(Sox2EGFP/IR; G). (H–J) Comparison of eye morphology of E14.5 Sox2+/EGFP, Sox2EGFP/IR, and Sox2EGFP/COND;P0-CRE mice. Bars: E,F,
50 µm; G, 100 µm; H–J, 200 µm.
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of Sox2 results in the loss of general retinal progenitor
cell characteristics: the ability to proliferate and appro-
priately differentiate. Consistent with previous reports
(Kammandel et al. 1999), we detected a variegated ex-
pression of the CREiresGFP transgene driven by the
combination of the  enhancer and P0 promoter of
Figure 4. Ablation of SOX2 expression from neural progenitors inhibits their proliferation and differentiation. Sox2 conditional
heterozygote (Sox2+/COND;P0-Cre; A), and homozygote (Sox2COND/COND;P0-Cre; F) littermates carrying P0-Cre transgene ex-
press CREiresGFP in distal retina (DR) at E13.5, as identified by antibody staining (red) and GFP expression (green). SOX2 expression
is maintained in the DR of the Sox2+/EGFP;P0-CRE mouse (B), while CRE-driven recombination eliminates SOX2 expression in the
DR of the Sox2COND/COND;P0-Cre; embryo (G). At E13.5, the loss of SOX2 expression in the neural progenitor cells of the DR
results in an overall hypocellularity of the Sox2COND/COND;P0-Cre (H), compared with the Sox+/COND;P0-Cre (C). Compared with
the Sox+/COND;P0-Cre, proliferation, progenitor marker expression and neuronal differentiation are obstructed in DR of
Sox2COND/COND;P0-Cre mice, as illustrated by the decreased incorporation of BrdU (D,I) and the absence of Notch1 (E,J), Hes-5
(K,P), Math5 (L,Q), NeuroD1 (M,R), and TUBULINIII (N,S) expression. By birth, the Sox2COND/COND;P0-Cre retina is comprised
of regions displaying varying degrees of cellular deterioration (T) compared with Sox2+/COND;P0-Cre retina (O). Bars, A–T, 100 µm.
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mouse Pax6 gene within the distal retina. The observed
variability was increased in Sox2COND/COND;P0-CRE
mice ranging from mosaic CREiresEGFP expression re-
stricted to the distal retina to widespread CREiresGFP
distribution throughout the circumference of the retina
(Supplementary Fig. 3, cf. A and D). The coincident ab-
lation of SOX2 with expression of CRE and the mutually
exclusive expression of neuronal differentiation marker
(TUBULINIII; red) and CREiresGFP (green) in
Sox2COND/COND;P0-CRE embryonic retinas (Fig. 4S;
Supplementary Fig. 3) indicates that SOX2 acts in a cell
autonomous manner. A cell-autonomous role for SOX2
in retinal neural progenitor cells could explain the vary-
ing degrees of retinal cell loss in Sox2COND/COND;P0-
CRE (Fig. 4T) compared with Sox2+/COND;P0-CRE
(Fig. 4O).
These results show that SOX2 plays a role in main-
taining retinal neural progenitors in an undifferentiated
proliferative state and, taken together with results from
studies of SOX2 in the developing neural tube, imply a
general requirement for SOX2 in neural progenitor cell
populations.
Eye morphogenesis in Sox2 hypomorphic mice
The progressive increase in the severity of eye pheno-
types displayed by mice carrying Sox2 mutant alleles
(Fig. 3H–J) strongly suggests that the level of SOX2 is
critical for normal retinal development. It is becoming
recognized that the absolute level of a specific transcrip-
tion factor is an important component of the mechanism
of lineage specific regulation (Kulessa et al. 1995;
DeKoter and Singh 2000; Motohashi et al. 2000, 2004;
Emambokus et al. 2003). Moreover, it has been proposed
that neural progenitor cell heterogeneity is triggered in
part through a gene-dosage effect (Marquardt and Gruss
2002; Sinor and Lillien 2004).
To directly determine the functional significance of
decreasing levels of SOX2 expression, we analyzed the
phenotypic and molecular consequences in retinal neu-
ral progenitors of Sox2 hypomorphic/null mouse mu-
tants (Sox2EGFP/IR and Sox2EGFP/LP). Gross morphologi-
cal analyses of Sox2EGFP/IR brains show hypoplasia of
optic nerves and chiasmata (Fig. 5A,E). RGCs are the
only retinal projection neurons to extend axons outside
the eye; their axons grow laterally toward the presump-
tive optic nerve head and pass outward through the optic
stalk to travel along the optic nerve to the chiasm. Thus,
the observed failure to form optic nerves in Sox2EGFP/IR
mice strongly suggests a defect in RGCs due to early
disruption of SOX2.
To determine whether the Sox2IR mutation affects dif-
ferentiation of retinal neurons, we used immunostaining
to evaluate the differentiation of distinct cell types in
postnatal Sox2EGFP/IR retinas. RGCs, as marked by
NEUROFILAMENT (Fig. 5B,F, arrows), BRN3b (Fig. 5C,G,
arrows), and ISLET1 (Fig. 5D,H, arrows) expression, are
absent. On the other hand, markers of amacrine cells
(CALRETININ, Fig. 5I,M, arrowheads), bipolar cells
(PKC, Fig. 5J,N), rod photoreceptors (RHODOPSIN, Fig.
5K,O, arrowhead) and horizontal cells (NEUROFILAMENT,
Fig. 5B,F, arrowhead) are expressed, and Müller glia
are formed in Sox2EGFP/IR retinas (GFAP, Fig. 5L,P;
CRABLP, Supplementary Fig. 4D,F). Interestingly, where-
as GFAP expression in the wild-type and heterozygous
(Sox2+/GFP) mouse retina is restricted to the distal region,
the Sox2EGFP/IR retina expresses GFAP throughout the
distal–central axis. Colabeling with CRABLP identified
these cells as Müller glia (Supplementary Fig. 4), which
in the central region of the wild-type mouse retina do not
normally express GFAP. Therefore, the observed in-
crease in GFAP expression in the Sox2EGFP/IR retina ap-
pears to be an up-regulation of GFAP in these cells and
not an increase in their cell number. In addition to an
apparent absence of RGCs, the majority of Sox2EGFP/IR
eyes show disrupted cell layering, which is demonstrated
by the presence of rosette structures (Figs. 3, 6 [cf. A–C
and D–F]). The rosette structures are comprised of
differentiated retinal neuronal subtypes. For example,
they contain rod cells (marked by RHODOPSIN,
Fig. 6C,F) surrounded by horizontal cells (marked by
NEUROFILAMENT, Fig. 6B,E) and amacrine cells
(marked by CALRETININ, Fig. 6A,D).
Reduction in SOX2 levels restricts retinal neural
progenitor competence
To determine whether RGCs are generated during em-
bryogenesis in Sox2EGFP/IR mice, we assessed Brn3b and
TUBULINIII expression, which at E15 identify differ-
entiating RGCs. In both the wild-type and Sox2EGFP/IR
mutant retina, Brn3b and TUBULINIII-positive cells
could be identified in the inner side of the developing
neural retina, consistent with the formation of RGCs
(Fig. 6G,L,H,M). Although RGCs were present in the
Sox2EGFP/IR mutant retina, the cells were inappropri-
ately localized. For example, TUBULINIII-positive cells
were not restricted to the inner side, but could also be
detected in the outer RBL layer, which normally at this
stage consists of undifferentiated progenitor cells (Fig.
6M, arrows). These regions contained fewer progenitors,
as marked by PCNA, and showed disruption of retinal
laminar structure (Fig. 6I,N, arrow). Moreover, the RGC
axons of Sox2EGFP/IR retinas, as marked by TUBULINIII
(Fig. 6, cf. H and M) and anterograde labeling of retinal
ganglion cells with Dextran-Cy3 (Fig. 6, cf. J and O, dot-
ted outline), are scattered to subretinal spaces and fail to
enter the optic nerve. This failure of SOX2 hypomorphic
RGCs to reach their target is consistent with an increase
in apoptotic cells as indicated by Caspase 3 staining (Fig.
6K,P).
Neural progenitor cells are characterized and defined
by their pseudoepithelial morphology, proliferative ca-
pacity, and gene-expression profiles. The disruption in
retinal structure and aberrant ganglion cell differentia-
tion in Sox2EGFP/IR retinas indicates a change in progeni-
tor properties due to a decrease in the level of SOX2. To
address this question and begin to determine the mo-
lecular basis for these defects, we examined the expres-
sion of markers that define progenitor cells and the onset
SOX2 and retinal progenitor fate
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of their differentiation in Sox2EGFP/IR mice, focusing on
regulators of RGC differentiation. A number of tran-
scription factors have been shown to serve as intrinsic
regulators of RGC differentiation, among them the ho-
meodomain factor PAX6 and basic helix–loop–helix
(bHLH) factors MATH5, NEUROD, HES-1, and HES-5,
GLI1 (Marquardt and Gruss 2002; Hatakeyama and
Kageyama 2004; Mu et al. 2005). PAX6 is required for the
activation of MATH5, an essential factor for RGC lin-
eage specification. NEUROD1, another member of
bHLH proneural genes, is also implicated in promoting
retinal neuronal differentiation. In contrast, the NOTCH
pathway negatively regulates RGC differentiation by ac-
tivating the Hairy-enhancer of Split (HES) family of
bHLH genes, Hes-1 and Hes-5, thereby repressing the
proneural bHLH factor Math5. Thus, the PAX6 and
NOTCH pathways counter each other in the regulation
of downstream genes required for the generation of the
RGC lineage. To assess the pathways disrupted in Sox2
mutants, we therefore compared Math5, NeuroD1, Gli1,
PAX6, Notch1, and Hes-5 expression between the wild-
type and Sox2 hypomorphic/null mutant retina. At E14
in both wild-type and Sox2EGFP/IR retinas, Math5, Neu-
roD, Gli1, and PAX6, are expressed at high levels in the
retinal outer layer (Fig. 7, cf. A–C,G,D–F,J) consistent
with progenitor cell differentiation and generation of
RGCs. In contrast, expression of Notch1 and Hes-5 (Fig.
7, cf. H,I and K,L), which function to repress RGC dif-
Figure 5. Decrease in SOX2 levels leads to hypoplasia of the optic nerve and loss of retinal ganglion cells. Ventral side of 3-mo-old
Sox2+/EGFP (A) and Sox2EGFP/IR (E) brains. (E) Note the absence of developed optic nerve (arrow) in Sox2EGFP/IR. Immunostained sections
through the retina of adult Sox2+/EGFP (B–D,I–L) and Sox2EGFP/IR (F–H,M–P) mice. Compared with the Sox2+/EGFP, Sox2EGFP/IR mice
show ∼95% reduction in the number of cells immunostained for NEUROFILAMENT (B,F, arrows), Brn3b (C,G, arrows), and ISLET1
(D,H, arrows), and a ∼60%–70% reduction in cells stained with CALRETININ (I,M, arrowhead) in the ganglion cell layer (GCL). In
contrast, interneurons demonstrate a relatively normal distribution, as shown by staining for NEUROFILAMENT (B,F, top arrow-
heads), ISLET1 (D,H), CALRETININ (I,M), and PKC (J,N). (I,M) Note the significant reduction in size of inner plexiform synaptic layer
(IPL) as visualized by CALRETININ staining (arrowheads). (K,O) No cell loss was apparent in outer nuclear layer (ONL) formed by
photoreceptor cell bodies, as confirmed by RHODOPSIN staining of the outer segments (arrowheads). (L,P) We noted an up-regulation
of GFAP expression in central retina of the Sox2EGFP/IR mice as compared with the Sox2+/EGFP mice (insets, gross morphology). Bars:
A,E, 2 µm; B–D,F–P, 100 µm; L,P (insets), 200 µm.
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ferentiation and maintain progenitor identity, are signifi-
cantly down-regulated in retinal progenitors of Sox2 hy-
pomorphs. Wild-type levels of Notch1 and Hes-5 expres-
sion are maintained in the neural tube where SOX2 is
coexpressed with SOX1 and SOX3, providing an internal
control for in situ staining (Supplementary Fig. 5A–D).
Furthermore, Western blot analyses of SOX2 and
NOTCH1 expression in retinal cells isolated from wild-
type, heterozygous, and hypomorphic/null Sox2 retinas
indicate that the decrease in levels of SOX2 expression
directly correlates with the decrease in levels of
NOTCH1 expression (Supplementary Fig. 5E).
In Sox2EGFP/IR mutant retinas, down-regulation of
SOX2 results in a decrease in the level of expression of
NOTCH1 and its direct downstream target Hes-5, while
expression of PAX6 and Math5 are up-regulated and Gli1
and NeuroD remain expressed. These data indicate that
SOX2 may maintain retinal progenitor identity, at least
in part, through the regulation of NOTCH1 signaling.
SOX2 transcriptionally regulates Notch1 expression
To establish whether Notch1 is directly regulated by
SOX2, and to elucidate the molecular mechanisms un-
Figure 6. Reduction of SOX2 expression disrupts retinal laminar morphology and impairs differentiation of RGCs. Immunostained
sections through the retina of P20 Sox2+/EGFP (A–C) and Sox2EGFP/IR (D–F) mice. Compared with the Sox2+/EGFP (A–C), Sox2EGFP/IR
(D–F), mice show disruption of retinal cell layers with rosette structure formation. The rosette structures contain rod cells (F,
RHODOPSIN, arrow) surrounded by horizontal cells (E, NEUROFILAMENT, arrow) and amacrine cells (D, CALRETININ, arrow).
Representative horizontal sections of E15.5 Sox2+/EGFP (G,H) and Sox2EGFP/IR (L,M) littermates immunostained for Brn3b and
TUBULINIII. Both embryos show the presence of GCL; however, the differentiating neurites in the compound null hypomorphic
retinas (L,M) do not form a distinguishable fiber layer, and in the majority of cases fail to enter the optic nerve; TUBULINIII-positive
cell bodies can be identified in the neuroblast layer (M, arrow). Compared with Sox2+/EGFP (I), these regions in Sox2EGFP/IR (N) retinas
contain fewer progenitor cells as marked by PCNA staining. Anterograde labeling of the E14.5 retina with Cy3-dextran confirmed the
loss of axonal projections from the retina in compound null hypomorphic retina (O, dotted outline), compared with the Sox2
heterozygote (J, dotted outline). (K) Quantitative analysis of cells immunoreactive for activated CASPASE3. Cells were counted from
horizontal section of E12, E14, and E15 mouse embryos; n = 4 at each age. (P) Representative section of E14 Sox2EGFP/IR retina
illustrating CASPASE-3 staining in GCL. Bars, A–F, 50 µm; G–I,L–N, 200 µm; J,D, 300 µm; P, 50 µm.
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derlying SOX2 function, we conducted a chromatin im-
munoprecipitation (ChIP) cloning screen—a method that
allows for the identification of direct downstream targets
of a transcription factor (Weinmann et al. 2002). To this
end, a library of ChIP DNA fragments was generated
from embryonic stem (ES) cells using a SOX2 polyclonal
antibody (Fig. 8A). Fifty clones were sequenced, and
BLASTed against the whole mouse genome to identify
the loci of the ChIP DNA fragments. Among the loci
identified was Fgf4, a well-characterized direct target of
SOX2 (Dailey et al. 1994). More critically we also iden-
tified a DNA fragment localized to intron 13 (IVS13) of
the Notch1 locus (Fig. 8C).
To further validate the in situ binding of SOX2 to the
IVS13 region of Notch1, and to demonstrate that the
same SOX2-dependent enhancer of Notch1 could be
ChIPed from CNS tissue, a ChIP PCR analysis (Fig. 8B)
was conducted using mouse ES cells, E14.5 CNS tissue,
and mouse embryonic fibroblasts (MEF, which lack
SOX2), as a negative control. The results show that
IVS13 of Notch1 is enriched upon ChIP in both ES cells
and E14.5 CNS, but not in MEFs, or when using a non-
specific IgG antibody (Fig. 8C).
The 2.0-kb Notch1 IVS13 DNA fragment identified by
ChIP was assessed for putative SOX2-binding sites. Bio-
informatic analysis identified three SOX consensus sites
within the 2.0-kb DNA fragment (Fig. 8D). To confirm
SOX2 binding to the putative cis elements, DNase I foot-
printing analysis was conducted using a 150-base-pair
(bp) probe that contained all three sites. Using HIS-
tagged purified SOX2 protein, three strong DNase I in-
terference patterns were observed, which directly corre-
late with the locations of the three SOX consensus se-
quences (Fig. 8E).
Furthermore, to determine whether the 150-bp frag-
ment had the ability to enhance transcription, the
Notch1 IVS13 fragment containing the SOX2 consensus
sites was cloned into a minimal promoter luciferase re-
porter gene construct (Tugores et al. 1994) that was tran-
siently transfected into the early ectodermal cell line
P19 (Fig. 8F). The results show that the 150-bp Notch1
IVS13 DNA fragment increases transcription compared
with the minimal promoter alone. Moreover, site-di-
rected mutagenesis of the +26988 and +27001 SOX2 cis
elements ablates any enhanced transcription, indicating
that the SOX2 consensus binding sites are critical for the
transcriptional enhancement of the reporter gene con-
struct. Together, these data strongly imply that Notch1
is transcriptionally regulated by SOX2.
Discussion
In this study we provide genetic evidence demonstrating
that alterations in the levels of SOX2 regulate the choice
between maintenance of retinal progenitor cell identity
and differentiation. Wild-type levels of SOX2 maintain
progenitor developmental potency, the ability to prolif-
erate and differentiate, while a decrease in SOX2 levels
(<40% of wild-type levels) results in the restriction of
progenitor competence including the disruption of neu-
roepithelial morphology, proliferative capacity, and ab-
errant differentiation. In part, these characteristics of de-
Figure 7. Expression of molecular regulators of RGC
differentiation in Sox2 hypomorphic mice. In situ hy-
bridization on sections from E14 Sox2+/EGFP (A–C,G–I)
and Sox2EGFP/IR (D–F,J–L) embryos with probes for tran-
scription factors involved in RGC differentiation. (A,D)
Math5. (B,E) NeuroD1. (C,F) Gli1. (H,K) Notch1. Hes-5
(I,L). (G,J) Immunostaining for PAX6. Bars, A–J, 200 µm.
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fective retinal development in a Sox2-deficient genetic
background are a consequence of altered NOTCH1 sig-
naling. Our study shows a direct relationship between
SOX2 and the Notch1 gene in that SOX2 interacts di-
rectly with a Notch1 enhancer, and that, in turn, the
levels of SOX2 directly correlate with the levels of
NOTCH1.
A role for SOX2 in vertebrate eye development was
first suggested based on its expression pattern; SOX2 is
expressed throughout the cells of optic vesicle of the
anterior neural plate, transiently expressed in the newly
induced lens, and is then restricted to proliferating pro-
genitor cells of the neural retina (Kamachi et al. 1998;
Van Raay et al. 2005). Consistent with its early expres-
sion in the anterior neural plate, inhibition of SOX2 sig-
naling by injection of antisense morpholinos or domi-
nant interfering forms of Sox2 into Xenopus embryos
results, in addition to other morphological effects, in re-
duced or missing eyes (Mizuseki et al. 1998; Van Raay et
al. 2005). Furthermore, misexpression of SOX2 in chick
embryos has been shown to induce ectopic lens forma-
tion as marked by -CRYSTALLIN (Kamachi et al. 2001).
In order to bypass the early requirement of SOX2 in the
anterior neural plate and to specifically address its role in
neural retinal progenitor cells, we used the Cre-loxP
strategy to conditionally inactivate Sox2 in the mouse.
Our results demonstrate that SOX2 is required for the
maintenance of neural retinal progenitor identity, such
that after Cre-mediated ablation of SOX2 activity in the
developing neuroretina, RPCs lose their ability to both
divide and differentiate. Consequently, neurogenesis, in-
cluding the up-regulation of bHLH factors (MATH5,
NEUROD1) and the appearance of TUBULINIII differenti-
ated neurons, was not observed in the Sox2COND/COND;
P0-CRE mutant retinas. The cellular and molecular
consequences of genetic ablation of Sox2 in progenitor
cells of the neural retina in the mouse and the morpho-
lino-knockdown of SOX2 in Xenopus further highlight
an evolutionarily conserved function and requirement of
SOX2 in retinal progenitor cell biology (Van Raay et al.
2005).
The complete genetic ablation of Sox2 described here
in retinal neural progenitor cells phenocopies inhibition
of SOX2 signaling in embryonic and adult neural tube
progenitors. First, expression of a dominant interfering
form of SOX2 in chick neural progenitors results in their
premature exit from cell cycle (Bylund et al. 2003; Gra-
ham et al. 2003). Second, the conversion of rat oligoden-
drocyte precursors (OPCs) into multipotent neural stem
cells (NSCL) is dependent on reinitiation of SOX2 ex-
pression, and inhibition of SOX2 signaling results in pre-
mature exit from cell cycle and neuronal differentiation
of OPCs (Kondo and Raff 2004). Finally, it has recently
been demonstrated that SOX2 expression is maintained
in neurogenic regions of the adult rodent nervous system
and that regulatory mutations of mouse Sox2 cause neu-
rodegeneration and impair adult neurogenesis (Ferri et al.
2004). The conserved requirement for SOX2 in the CNS
ventricular zone and retinal progenitors suggests that
a common SOX2-regulated mechanism regulates the
Figure 8. SOX2 binds IVS13 cis elements in the Notch1 gene.
(A) Whole-cell extracts from ES cells and Control STO cells
(which lack SOX2) were incubated with SOX2 antibody. SOX2
was efficiently immunoprecipitated (IPed) from only the ES cell
extracts. (B) Schematic representation of standard ChIP PCR
assay. PCR primers flanking the SOX2 consensus cis elements
were used in a standard ChIP PCR assay with DNA template
IPed from ES cells, E14.5 CNS, or MEFs as a control. Sonicated
DNA was volumetrically divided in half to ensure equivalent
input templates, and ChIP was conducted with either a SOX2 or
nonspecific IgG as a control antibody. (C) The Notch1 IVS13
locus was IPed as a direct function of SOX2 binding in both ES
cells and E14.5 CNS, but not from MEFs (which lack SOX2).
Known SOX2 cis elements positioned in well-characterized en-
hancers of Fgf4 and Nestin were used as positive controls to
demonstrate efficient ChIP using the SOX2 antibody. (D) Probe
sequence used for DNase I footprinting analysis. Numbers in-
dicate the nucleotide positions of the SOX2 consensus sites
within Notch1. The underlined sequence represents the area of
the footprint pattern. Red boxes indicate bases in the SOX2
consensus sites that were mutated (+26988: TG to CC, and
+27001: TGT to GCA). (E) DNase I footprinting demonstrates
the binding of proteins that produce interference patterns that
localize specifically to SOX2 consensus sites within the Notch1
IVS13. Numbered arrows on the left indicate the location of the
SOX2 consensus sites in the probe. The schematic diagram on
the right represents the approximate locations of SOX2 binding
to the probe. (F, left schematic) Luciferase reporter gene con-
structs were generated that contained the intact 150-bp IVS13
DNA fragment or the same DNA fragment in which either the
+26988 or +27001 SOX2 consensus sites were mutated. (Right
graph) Transient transfections in P19 cells indicate that the 150-
bp IVS13 of Notch1 has the ability to enhance transcription of
the reporter gene by approximately threefold, and that the
+26988 and +27001 SOX2 consensus sites are required for tran-
scriptional enhancement.
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maintenance of progenitor cell identity in distinct re-
gions of the CNS.
Despite mounting evidence that SOX2 is important in
the maintenance of progenitor cell identity (Bylund et al.
2003; Graham et al. 2003; Ferri et al. 2004), the question
remains: Does SOX2 interact with other genetic path-
ways implicated in this process, and if so, how? The
maintenance of CNS progenitor identity is critically de-
pendent on NOTCH signaling. NOTCH1, along with its
two direct downstream targets HES-1 and HES-5, is co-
expressed in the ventricular zone of the developing cen-
tral nervous system including the retina, and maintains
RPCs in an uncommitted state (Hatakeyama and
Kageyama 2004; Hatakeyama et al. 2004). Moreover, the
transition from uncommitted to lineage-restricted RPCs
is coupled with both the down-regulation of NOTCH1
activity, presumably in response to extrinsic signals, and
the activation of retinogenic bHLH factors such as
MATH5, NEUROD1, and NGNs. However, what trig-
gers the transition from an “uncommitted RPC” to a
“lineage-restricted RPC” still remains unclear; for ex-
ample, what intrinsic differences occur in RPCs when
challenged with the same extrinsic signals?
Restriction of neural progenitor cell capacity is di-
rectly coupled with the down-regulation of SOX2 expres-
sion. Heterogeneity in SOX2 levels among progenitors
could therefore allow cells to respond differently to the
same extrinsic signals. By generating an allelic series of
Sox2 to directly analyze the effects of graded reduction of
SOX2, we provide genetic evidence that one of the in-
trinsic differences in progenitor cells is the level of
SOX2, which may act by modulating NOTCH1 expres-
sion in neural progenitors. We present three independent
sets of experiments demonstrating that Notch1 tran-
scription is regulated by SOX2; an unbiased ChIP screen
identified Notch1 as a direct target of SOX2 in vivo,
DNase footprinting and Luciferase reporter assays
showed that SOX2 can bind to Notch1 regulatory regions
and regulate the levels of NOTCH1 expression in vitro,
and finally, both NOTCH1 and its target Hes-5 are dra-
matically down-regulated in the retinas of Sox2 hypo-
morphic mice. Furthermore, ablation of NOTCH1 gives
a retinal phenotype similar to that which we describe for
Sox2-null mice (i.e., loss of RPCs) (Austin et al. 1995;
Waid and McLoon 1995; Ahmad et al. 1997; Henrique et
al. 1997; Jadhav et al. 2006), and the retinal phenotypes
of both Hes-1 and Hes-5 mutant mice are strikingly simi-
lar to the phenotype observed in Sox2-hypomorphic
mice, in that RPCs aberrantly differentiate and abnormal
“rosette-like” structures are present (Ishibashi et al.
1994; Tomita et al. 1996). The lack of balance between
lateral inhibitory signaling by NOTCH1 and proneural
gene products results in differentiation of RPCs—a
mechanism that may extend to other CNS progenitors.
The data presented in this study provide a molecular
explanation for the inverse correlation between the lev-
els of proneural bHLH and SOXB1 factor expression in
chick spinal-cord progenitor cells in that the capacity of
proneural bHLH proteins to direct neuronal differentia-
tion crucially depends on the suppression of SOX1,
SOX2, and SOX3 (Bylund et al. 2003). In light of the
conserved expression/function of NOTCH1 signaling in
other stem cell/progenitor populations, and the ability of
other SOX proteins to bind the loose SOX consensus
sequence, other SOX family members may act in a simi-
lar manner to universally conserve the “stemness” iden-
tity. Consistent with this, SOX10 has been implicated to
act in a dosage-dependent manner in the peripheral ner-
vous system to maintain neural crest stem cell identity
by indirectly regulating the expression of bHLH factors
(Kim et al. 2003).
Our data show that cell fate determination of retinal
progenitor cells is dependent on the levels of SOX2; how-
ever, the molecular mechanism by which SOX2 dosage
regulates cell fate remains to be elucidated. To date, two
major mechanisms of transcriptional regulation by SOX
factors have been suggested; protein–protein interaction
and modification of chromatin structure (Pevny and Lov-
ell-Badge 1997; Kamachi et al. 1999). The expression of
FGF4 and NESTIN, both previously identified as direct
transcriptional targets of SOX2, is dependent on het-
erodimerization of SOX2 with protein partners, OCT3/4
and Brn2, respectively (Tanaka et al. 2004). In the con-
text of an interacting protein network, it is possible that
subtle differences in protein levels are sufficient to shift
the equilibrium toward another transcription complex.
Furthermore, binding of SOX factors, including SOX2,
change the local conformation of DNA; i.e., introducing
or stabilizing bends that may determine the accessibility
of DNA to other transcription complexes (Scaffidi and
Bianchi 2001). It is tempting to speculate that transcrip-
tional networks, such as those including SOX factors, are
highly sensitive to a dosage effect that can modify their
capacity to form particular protein–protein interactions
and/or affect changes in higher order chromatin struc-
tures. Precedent for this comes from studies of mecha-
nisms regulating hematopoietic stem cell differentia-
tion. For example, a gradient of the E2A transcription
factor has been shown to determine the choice between
stem, B- or T-cell fate. Moreover, based on NOTCH1
signaling studies, a reduction in E2A function in the
common lymphoid precursor is permissive for T-cell lin-
eage but not for the B-cell lineage that requires intact
E2A activity (Zhuang et al. 2004).
The critical importance of precise regulation of tran-
scription-factor dosage is further reinforced by the genet-
ics of human syndromes. Humans with mutations in
SOX2 display a spectrum of severe eye malformations
ranging from unilateral microphthalmia to bilateral an-
ophthalmia including, in some cases, aplasia of the optic
nerve, chiasm, and optic tract. The severity of the dis-
ease state most likely reflects genetic variations within
the human population, or alternatively, reflects the
strength of the SOX2 mutation (e.g., null vs. hypomor-
phic). Detailed analyses of the cellular defects and mo-
lecular pathways associated with human SOX2-related
retinal defects have been difficult to assess in patients,
since the onset of the defect is developmental. Therefore,
a viable approach to circumvent this problem is to gen-
erate a mouse model in which the earliest phenotypic
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sequelae of aberrant SOX2 expression can be monitored
and studied in the embryo. Our analyses of an allelic
series of Sox2 mutations in the mouse have confirmed a
critical relationship between gene dosage of Sox2 and the
severity of eye malformations. Micropthalmic and optic
nerve hypoplasia was observed in Sox2COND/COND;P0-
CRE animals, thus implicating the disruption of SOX2
function specifically in the neural retina as a contribut-
ing factor to the phenotype observed in human SOX2-
Anophthalmia. Compound hypomorphic null mice
(Sox2EGFP/LP, Sox2EGFP/IR) display a series of eye malfor-
mations, and in most severe cases, both eyes fail to de-
velop (bilateral anophthalmia). Moreover, we have dem-
onstrated that these differences in the severity of eye
phenotypes correlate with the defects in the neural
retina, and they are directly related to the levels of SOX2
expression. Although the phenotype observed in Sox2-
hypomorphic mice (compound heterozygotes) closely
mimics that displayed in humans with SOX2 mutations,
the defect in humans is primarily defined as a heterozy-
gous disorder where one allele possesses a missense or
null mutation, and the other allele is “wild type.” Al-
though we cannot rule out that species differences may
account for a phenotypic difference between mouse and
human, an intriguing point of speculation based on the
genetic consequences of the Sox2-hypomorphic mouse is
that humans with SOX2-related retinal defects may in-
deed be compound heterozygotes; that is, they may pos-
sess a null allele and a “low-expressing” allele that
brings the total functional level of SOX2 to phenotypic
levels (<40% of normal). The literature is replete with
examples of human disorders in which a low-expressing
allele, combined with a null-allele, precipitates the dis-
ease condition. The molecular defects associated with a
“low-expressing allele” range from enhancer defects to
aberrant splicing and mRNA stability. Our study may
shed light on potential regulatory mutations in the “un-
explored” allele from cohorts already identified to pos-
sess a null-SOX2 allele. An alternative hypothesis is that
humans with SOX2-related eye disorders have epistatic
mutations or complex genetic interactions that result in
retinal and/or lens defects. The Sox2EGFP and Sox2-hy-
pomorphic mice provide critical genetic tools to identify
interacting pathways necessary for normal eye develop-
ment and causative to pathologic conditions.
Materials and methods
Gene targeting and mouse breeding
The Sox2COND targeting construct was generated by inserting a
loxP site in the SpeI site 5 of the first Sox2 exon and a PGK–Neo
cassette flanked by a loxP site in the NheI site immediately 3
to the Sox2 coding region (Avilion et al. 2003). The Sox2LP tar-
geting construct was created by partial incorporation of the
Sox2COND targeting vector into Sox2 locus. This introduced the
PGK–Neo cassette with a single loxP site into the first NheI site
3 of Sox2 coding sequence (Fig. 2A). In the Sox2IR construct, the
3UTR of Sox2 mRNA (EcoRV–NheI fragment) was replaced
with IRESdsRed2 (Clontech) and loxP-flanked PGK–Neo cas-
sette (Fig. 2C). Targeted constructs were electroporated into
CCE ES cells (gift from E. Robertson, Oxford University,
Oxford, UK) and recombinants were identified using standard
Southern blot analysis with P32dCTP DNA probes (Fig. 2B,D).
Chimeric founder mice that transmitted the targeted alleles
were produced by blastocyst injection. Sox2COND mice were
generated by mating heterozygous Sox2COND mice to ACTB-
Cre FVB/N-Tg(ACTB-cre)2Mrt/J, in which CRE recombinase is
expressed in the female germline (Jackson Laboratories) (Lewan-
doski et al. 1997) and P0-Cre mouse line (gift from Dr. P.
Gruss, Max-Planck-Institute of Biophysical Chemistry, Ger-
many) (Marquardt et al. 2001). PCR genotyping of Sox2 alleles
was performed using the following sets of primers: for the wild-
type allele (Sox2+) 5-GCTCTGTTATTGGAATCAGGCTGC
3 and 5-CTGCTCAGGGAAGGAGGGG-3 primers; 35 cycles
at 94°C for 15 sec, at 55°C for 30 sec, at 72°C for 30 sec; gen-
erated 382-bp product; for targeted alleles (Sox2COND, Sox2LP
and Sox2IR) 5-CAGCAGCCTCTGTTCCACATACAC-3 and
5-CAACGCATTTCAGTTCCCCG-3 primers; 35 cycles at
94°C for 15 sec, at 56°C for 30 sec, at 72°C for 40 sec; generated
297-bp product. The Sox2COND allele was detected using 5-
CTTCTTTCCGTTGATGCTTTCG-3 and 5-ATCTTGGTG
GCTGAACAGTTATCC-3 primers; 35 cycles at 94°C for 15
sec, at 55°C for 30 sec, at 72°C for 40 sec; by 589-bp product.
Sox2EGFP allele (Ellis et al. 2004) was genotyped using 5-
CGCTTCCTCGTGCTTTACG-3 and 5-GGCTTCTCCTTT
TTTTGCAGT-3 primers; 35 cycles at 94°C for 15 sec, at 60°C
for 30 sec, at 72°C for 45 sec; by 750-bp product.
Northern blot analysis
Total RNA was extracted from E14 mouse brains using Trizol
reagent (Invitrogen) and analyzed by Northern blotting using
P32dCTP DNA probes for Sox2 (PS2, Fig. 2A) and -Actin (939-
bp fragment generated using 5-GTGACGAGGCCCAGAG
CAAGAG-3 and 5-AGGGGCCGGACTCATCGTA-3 prim-
ers). The blots were developed using a PhosphorImaging Ty-
phoon scanner (Amersham Biosciences) and quantified using
ImageQuant (Amersham Biosciences).
Immunoblotting
Protein extracts were prepared from E14 embryonic brains or
eyes in RIPA buffer (Magness et al. 1998) containing protease
inhibitor cocktail (Sigma). Immunoblotting was conducted ac-
cording to standard protocol using primary antibodies against
SOX2 (Chemicon; 1:1000), EGFP (Molecular Probes; 1:5000),
NOTCH1 (Santa Cruz Biotechnology; 1:1000) and ACTIN
(Sigma; 1:5000). IgG-horseradish conjugate (Bio-Rad) was ap-
plied as the secondary antibody (1:10,000) and Enhanced Che-
miluminescence Reagent (Amersham) was used for detection.
Bands were quantified by scanning the film and the image den-
sities analysis using NIH Image software (http://rsb.info.nih.
gov/nih-image/Default.html).
Tissue preparation, immunohistochemistry, and in situ
hybridization
Mouse embryos were fixed with 4% paraformaldehyde (PFA) in
phosphate-buffered saline (PBS). Adult mice were perfused with
4% PFA and the eyes and brains were post-fixed for 30 min at
room temperature. Tissue was immersed sequentially in 10%,
20%, and 30% sucrose/PBS and then embedded and frozen in
OCT medium (Tissue-Tek). For BrdU labeling, pregnant mice
were injected intraperitoneally with BrdU (100 mg per kilogram
of body mass) and euthanized 2 h thereafter. Horizontal 12–14
µm cryostat sections were blocked in 1% goat serum in PBS/
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0.1% Triton-X 100 and incubated with primary antibodies at
4°C overnight and with secondary antibodies for 20 min at room
temperature. Working dilutions and sources of the following
antibodies were used in this study: SOX2 (Chemicon; 1:2000),
SOX1 (Pevny et al. 1998) (1:500), PCNA (Biosource Interna-
tional; 1:500), BrdU (Becton Dickinson; 1:100), TUBULINIII
(Covance; 1:1000), NEUROFILAMENT (Hybridoma Bank;
1:5000), CRALBP (1:4000), GFAP (DAKO; 1:500), PAX6 (Hybrid-
oma Bank; 1:50), PAX6 (Covance; 1:200), ISLET1 (Hybridoma
Bank; 1:50), CALRETININ (Chemicon; 1:1000), Protein Kinase
C  (Sigma; 1:1000), RHODOPSIN (Leinco Technologies; 1:50),
Cre-recombinase (Novagene; 1:2000), activated CASPASE3
(Cell Signaling Technology; 1:50), Cy3-anti-mouse (Sigma;
1:200), Cy3-anti-rabbit (Sigma; 1:200). In situ hybridization was
performed on 20-µm horizontal cryostat sections using DIG-
labeled antisense RNA probes and followed by enzymatic de-
tection according to manufacture protocols (Roche). The follow-
ing probes were used: Math5 (Yang et al. 2003), NeuroD1 (Lee et
al. 1995), Notch1 (Lardelli and Lendahl 1993), and Hes-5 (Chenn
and Walsh 2002).
ChIP library and PCR analysis
A SOX2 ES ChIP library was generated essentially as described
in Weinmann and Farnham (2002). Anti-SOX2 antibody
(Chemicon; 2.5 µg/mL) was used for IP with Protein A/G Aga-
rose Plus (Santa Cruz Biotechnology) beads. ChIP material (1–4
µl) was used in a Zero-blunt TOPO cloning reaction (Invitrogen)
and ChIP DNA fragments were sequenced. ChIP PCR analysis
from isolated ES, MEF, and E14 mouse CNS cells was conducted
using the gene-specific oligonucleotides Notch1, 5-GTACC
CACCTGGCCCAAGA-3 and 5-GGTGACAGCAGCCCTTT
GTC-3; Nestin, 5-CTGAGAATTCCCACTTCCCCT-3 and
5-CCTCAGATCAGTCTCCGCCTC-3; FGF4, 5-CCAAAAT
GGAAGAGCAGGGTC-3 and 5-GCACCTAAGGAGTGGG
CGTG-3; at 94°C for 15 sec, at 59°C for 10 sec, and at 72°C for
45 sec; for 32–35 cycles to maintain PCR in linear range.
Footprinting protection assay
Full-length HIS-tagged SOX2 (pcDNA3.1- SOX2-V5HIS) was
transiently expressed in 293 cells, purified with Ni-NTA beads
according to manufacturer’s protocol (Qiagen), and dialyzed
against Dignam C with 50 mM NaCl. Purification was assessed
by Coomassie-stained SDS-PAGE gels and immunoblotting. A
footprinting assay was conducted essentially as described (Tu-
gores et al. 1994) using 30 µg of purified SOX2-V5-HIS, dGdC,
and a probe generated from the 150-bp amplicon recovered by
PCR using the Notch1 primers described above.
Luciferase assay
The 150-bp DNA fragment (IVS13) used in the DNase I foot-
printing assay was cloned into the 3 polylinker of p21LUC,
which contains a minimal promoter driving expression of Pho-
tinus pyralis luciferase. Site-directed mutagenesis was carried
out on the SOX2 consensus sites, +26988 and +27001, located in
the 150-bp Notch1 IVS13 DNA fragment. The mutations were
induced with the PCR primers +26988FOR (5-CAGAGGGT
CAGCATCCTCAAGGTGGCATTG-3 and the complemen-
tary primer) or +27001FOR (5-CATTGTCAAGGTGGCAT
GCATCCAGTCTGGAACCCTTG-3 and the complementary
primer) using a modified QuickChange method (Stratagene).
The +26988 site was converted from ATTGTC to ATCCTC and
the +27001 site was converted from ATTGTT to ATGCAT.
Notch1 IVS13 luciferase reporter gene constructs (1 µg/40
wells), and CMV-Renilla luciferase (0.2 µg/well) as a normaliza-
tion control, were transiently transfected into the P19 cell line
using Lipofectamine Plus reagent (Invitrogen) in OptiMEM me-
dium (Gibco). After 12 h of exposure to transfection medium,
the medium was replaced with DMEM-H (Gibco) supplemented
with standard concentrations of glutamine, penicillin, and
streptomycin, and incubated for an additional 36 h. Forty-eight
hours after transfection, the expression of both P. pyralis and
Renilla Luciferase were assessed using the Dual Luciferase Re-
porter Assay System (Promega). All experiments were carried
out in duplicate, and the transfection efficiency of Notch1
IVS13 reporter genes was normalized to CMV-Renilla luciferase
activity.
Fluorescence-activated cell sorting (FACS)
Retinas from E13.5 wild-type (Sox2+/COND;P0-CRE) and mu-
tant (Sox2COND/COND;P0-CRE) dissociated as described in
Polleux and Ghosh (2002). Live cells (106) were stained for 30
min at 37°C with Vibrant Violet dye (Invitrogen) and then sub-
jected to FAC analysis using a CyAn flowcytometer (DAKO
Cytomation, Glostrup). DNA content was determined specifi-
cally in P0-CREiresGFP cells by gating on EGFP-positive cells
and assessing Vybrant Violet fluorescence. DNA Content his-
tograms were modeled for cell cycle parameters in 30,000 cells
using MODFIT software (Verity).
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